✦ LIBER ✦

Ras interference as cancer therapy

✍ Scribed by Anja M Duursma; Reuven Agami

Book ID: 114340624
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 168 KB
Volume: 13
Category: Article
ISSN: 1044-579X
DOI: 10.1016/s1044-579x(03)00040-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

K-ras as a target for cancer therapy

✍ Bret B. Friday; Alex A. Adjei 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 351 KB

RNA Interference and Cancer Therapy

✍ Zhaohui Wang; Donald D. Rao; Neil Senzer; John Nemunaitis 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 315 KB

Tailoring Ras-pathway—Inhibitor combinat

Tailoring Ras-pathway—Inhibitor combinations for cancer therapy

✍ Roy Blum; Yoel Kloog 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Prospects of RNA interference therapy fo

Prospects of RNA interference therapy for cancer

✍ Pai, S I; Lin, Y-Y; Macaes, B; Meneshian, A; Hung, C-F; Wu, T-C 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 267 KB

Smoking interferes with therapy of RA an

Smoking interferes with therapy of RA and PsA, induces chemotaxis and impairs vascular function in RA

✍ Harty, L. C.; McCormick, J.; Connolly, M.; Fearon, U.; Veale, D. J. 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 80 KB

Selective GRB2 SH2 inhibitors as anti-Ra

Selective GRB2 SH2 inhibitors as anti-Ras therapy

✍ Brigitte Gay; Stéphanie Suarez; Giorgio Caravatti; Pascal Furet; Thomas Meyer; J 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 218 KB

Given the key role of Ras in the mitogenic signaling by receptor tyrosine kinases, several targets upstream of Ras may prove to be excellent targets for drugs in the treatment of cancer caused by oncogenic tyrosine kinases. CGP78850 is a potent competitor of Grb2 SH2-phosphopeptide interactions. Thi